Jazz Pharmaceuticals Shares Outstanding 2007-2019 | JAZZ

Jazz Pharmaceuticals shares outstanding history from 2007 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Jazz Pharmaceuticals shares outstanding for the quarter ending March 31, 2019 were 0.058B, a 5.06% decline year-over-year.
  • Jazz Pharmaceuticals 2018 shares outstanding were 0.061B, a 0.16% decline from 2017.
  • Jazz Pharmaceuticals 2017 shares outstanding were 0.061B, a 0.89% decline from 2016.
  • Jazz Pharmaceuticals 2016 shares outstanding were 0.062B, a 1.85% decline from 2015.
Jazz Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2018 61
2017 61
2016 62
2015 63
2014 63
2013 62
2012 60
2011 47
2010 39
2009 30
2008 26
2007 14
2006 0
2005 0
Jazz Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 58
Q4 2018 61
Q3 2018 62
Q2 2018 61
Q1 2018 61
Q4 2017 61
Q3 2017 61
Q2 2017 61
Q1 2017 61
Q4 2016 62
Q3 2016 62
Q2 2016 62
Q1 2016 63
Q4 2015 63
Q3 2015 63
Q2 2015 63
Q1 2015 63
Q4 2014 63
Q3 2014 63
Q2 2014 62
Q1 2014 59
Q4 2013 62
Q3 2013 62
Q2 2013 62
Q1 2013 62
Q4 2012 60
Q3 2012 61
Q2 2012 61
Q1 2012 58
Q4 2011 47
Q3 2011 47
Q2 2011 47
Q1 2011 46
Q4 2010 39
Q3 2010 42
Q2 2010 35
Q1 2010 35
Q4 2009 30
Q3 2009 31
Q2 2009 29
Q1 2009 29
Q4 2008 26
Q3 2008 27
Q2 2008 24
Q1 2008 24
Q4 2007 14
Q3 2007 24
Q2 2007 8
Q1 2007 0
Q4 2006 0
Q3 2006 13
Q2 2006 0
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $7.576B $1.891B
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $54.701B 34.95
Takeda Pharmaceutical (TAK) Japan $27.841B 8.17
Grifols (GRFS) Spain $13.524B 17.10
Sage Therapeutics (SAGE) United States $9.300B 0.00
Ionis Pharmaceuticals (IONS) United States $9.155B 20.01
Neurocrine Biosciences (NBIX) United States $7.798B 0.00
Catalent (CTLT) United States $7.372B 29.58
Nektar Therapeutics (NKTR) United States $6.160B 10.04
Tilray (TLRY) Canada $4.421B 0.00
FibroGen (FGEN) United States $3.838B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.489B 12.24
United Therapeutics (UTHR) United States $3.444B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.608B 393.00
PTC Therapeutics (PTCT) United States $2.507B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.028B 7.30
Xencor (XNCR) United States $1.953B 53.31
Portola Pharmaceuticals (PTLA) United States $1.903B 0.00
Tricida (TCDA) United States $1.847B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.802B 87.26
Ironwood Pharmaceuticals (IRWD) United States $1.788B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.773B 24.24
Zogenix (ZGNX) United States $1.714B 0.00
USANA Health Sciences (USNA) United States $1.681B 14.61
Madrigal Pharmaceuticals (MDGL) United States $1.620B 0.00
Aerie Pharmaceuticals (AERI) United States $1.510B 0.00
Heron Therapeutics (HRTX) United States $1.436B 0.00
Esperion Therapeutics (ESPR) United States $1.363B 0.00
Turning Point Therapeutics (TPTX) United States $1.297B 0.00
Corcept Therapeutics (CORT) United States $1.209B 17.26
Radius Health (RDUS) United States $1.127B 0.00
ArQule (ARQL) United States $1.058B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.945B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.944B 0.00
Endo (ENDP) Ireland $0.898B 1.44
Aptorum Group (APM) China $0.739B 0.00
CannTrust Holdings (CTST) Canada $0.733B 0.00
Odonate Therapeutics (ODT) United States $0.707B 0.00
Organogenesis Holdings (ORGO) United States $0.675B 0.00
TherapeuticsMD (TXMD) United States $0.654B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.583B 0.00
Translate Bio (TBIO) United States $0.571B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.560B 0.00
Dermira (DERM) United States $0.538B 0.00
Akebia Therapeutics (AKBA) United States $0.532B 0.00
ChemoCentryx (CCXI) United States $0.497B 0.00
GlycoMimetics (GLYC) United States $0.496B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.452B 22.80
Flexion Therapeutics (FLXN) United States $0.446B 0.00
Siga Technologies (SIGA) United States $0.435B 1.03
Collegium Pharmaceutical (COLL) United States $0.404B 0.00
TCR2 Therapeutics (TCRR) United States $0.400B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.397B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.386B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
Karyopharm Therapeutics (KPTI) United States $0.362B 0.00
KalVista Pharmaceuticals (KALV) United States $0.353B 0.00
Forty Seven (FTSV) United States $0.336B 0.00
Rafael Holdings (RFL) United States $0.335B 0.00
ImmunoGen (IMGN) United States $0.317B 0.00
CASI Pharmaceuticals (CASI) United States $0.306B 0.00
OptiNose (OPTN) United States $0.300B 0.00
Molecular Templates (MTEM) United States $0.296B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.294B 0.00
Harpoon Therapeutics (HARP) United States $0.294B 0.00
Xeris Pharmaceuticals (XERS) United States $0.280B 0.00
Concert Pharmaceuticals (CNCE) United States $0.267B 0.00
Dova Pharmaceuticals (DOVA) United States $0.252B 0.00
Aratana Therapeutics (PETX) United States $0.242B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.240B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.232B 0.00
Lannett Co Inc (LCI) United States $0.223B 2.17
Recro Pharma (REPH) United States $0.217B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.215B 0.00
Aclaris Therapeutics (ACRS) United States $0.211B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.204B 0.00
Bio Blast Pharma (ENLV) Israel $0.197B 0.00
Aldeyra Therapeutics (ALDX) United States $0.194B 0.00
Ocular Therapeutix (OCUL) United States $0.191B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.190B 0.00
MEI Pharma (MEIP) United States $0.185B 0.00
Galectin Therapeutics (GALT) United States $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.177B 57.38
Minerva Neurosciences (NERV) United States $0.175B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.172B 0.00
Opexa Therapeutics (ACER) United States $0.169B 0.00
Calithera Biosciences (CALA) United States $0.160B 0.00
Jounce Therapeutics (JNCE) United States $0.160B 0.00
Ardelyx (ARDX) United States $0.160B 0.00
IMV INC (IMV) Canada $0.157B 0.00
Redhill Biopharma (RDHL) Israel $0.154B 0.00
AgeX Therapeutics (AGE) United States $0.147B 0.00
Majesco Entertainment (PTE) United States $0.145B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.137B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.136B 0.00
Aquestive Therapeutics (AQST) United States $0.120B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.118B 0.00
Tyme Technologies (TYME) United States $0.113B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.112B 0.00
MediWound (MDWD) Israel $0.099B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Cardiome Pharma (CORV) Canada $0.097B 0.00
Mast Therapeutics (SVRA) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.096B 68.78
DURECT (DRRX) United States $0.094B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.093B 0.00
Avenue Therapeutics (ATXI) United States $0.093B 0.00
Natural Alternatives (NAII) United States $0.092B 9.21
Iterum Therapeutics (ITRM) Ireland $0.090B 0.00
Infinity Pharmaceuticals (INFI) United States $0.090B 0.00
Capnia (SLNO) United States $0.087B 0.00
Nivalis Therapeutics (ALPN) United States $0.084B 0.00
China SXT Pharmaceuticals (SXTC) China $0.080B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.080B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Adherex Technologies (FENC) United States $0.078B 0.00
Melinta Therapeutics (MLNT) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
Novan (NOVN) United States $0.069B 0.00
Neos Therapeutics (NEOS) United States $0.065B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.062B 0.00
ElectroCore (ECOR) United States $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Genocea Biosciences (GNCA) United States $0.054B 0.00
KemPharm (KMPH) United States $0.053B 0.00
AIT Therapeutics (AITB) Israel $0.053B 0.00
Zafgen (ZFGN) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.049B 0.00
ProNAi Therapeutics (SRRA) Canada $0.049B 0.00
India Globalization Capital (IGC) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Lipocine (LPCN) United States $0.045B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.042B 0.00
Bio-Path Holdings (BPTH) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
ContraFect (CFRX) United States $0.037B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
PharmAthene (ALT) United States $0.031B 0.00
IsoRay (ISR) United States $0.028B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.028B 0.00
Heat Biologics (HTBX) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.025B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Regulus Therapeutics (RGLS) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 1.60
Pain Therapeutics (SAVA) United States $0.020B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
PRECISION THERAPEUTICS INC (POAI) United States $0.017B 0.00
Achieve Life Sciences (ACHV) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
VAXART, INC (VXRT) United States $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.011B 1.78
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00